Nabriva Therapeutics Plc Overview

Nabriva Therapeutics Plc Cost of Revenue

Cost of Revenue analysis for NBRV.

Quarterly Cost of Revenue

$4.44M

↑ 32.04% YoY

As of Mar 31, 2023

Annual Cost of Revenue (TTM)

$29.66M

↑ 80.32% YoY

Trailing 12 months ending Mar 31, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin